Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$5.37+0.03 (+0.56%)
Close on Nov 12, 2026Market cap $337.47MP/E –Yield –
Cytosorbents operating margin
Operating margin is operating income as a percentage of revenue.
Cytosorbents's operating margin for the twelve months ending Jun 30, 2026 was -34.7%. For fiscal 2025 it was -39.8%, against -46.2% the year before. The highest annual figure on record is -25.3% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -39.8% | +6.4 |
| FY2024 | Dec 31, 2024 | -46.2% | +56.6 |
| FY2023 | Dec 31, 2023 | -102.8% | −11.9 |
| FY2022 | Dec 31, 2022 | -90.9% | −38.2 |
| FY2021 | Dec 31, 2021 | -52.7% | −27.4 |
| FY2020 | Dec 31, 2020 | -25.3% | +50.8 |
| FY2019 | Dec 31, 2019 | -76.0% | −6.8 |
| FY2018 | Dec 31, 2018 | -69.3% | −4.3 |
| FY2017 | Dec 31, 2017 | -65.0% | +55.7 |
| FY2016 | Dec 31, 2016 | -120.6% | +73.5 |
| FY2015 | Dec 31, 2015 | -194.2% | −27.0 |
| FY2014 | Dec 31, 2014 | -167.2% | +27.4 |
| FY2013 | Dec 31, 2013 | -194.5% | +65.4 |
| FY2012 | Dec 31, 2012 | -259.9% | +12037.8 |
| FY2011 | Dec 31, 2011 | -12297.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -27.4% | +10.2 |
| Q1 FY2026 | Mar 31, 2026 | -34.3% | +10.2 |
| Q4 FY2025 | Dec 31, 2025 | -47.5% | −10.4 |
| Q3 FY2025 | Sep 30, 2025 | -30.2% | +25.9 |
| Q2 FY2025 | Jun 30, 2025 | -37.6% | +2.8 |
| Q1 FY2025 | Mar 31, 2025 | -44.6% | +7.2 |
| Q4 FY2024 | Dec 31, 2024 | -37.1% | +71.4 |
| Q3 FY2024 | Sep 30, 2024 | -56.1% | +27.3 |
| Q2 FY2024 | Jun 30, 2024 | -40.4% | +29.2 |
| Q1 FY2024 | Mar 31, 2024 | -51.8% | +31.7 |
| Q4 FY2023 | Dec 31, 2023 | -108.5% | −40.8 |
| Q3 FY2023 | Sep 30, 2023 | -83.4% | +27.7 |
| Q2 FY2023 | Jun 30, 2023 | -69.6% | +28.7 |
| Q1 FY2023 | Mar 31, 2023 | -83.5% | +6.1 |
| Q4 FY2022 | Dec 31, 2022 | -67.7% | +21.0 |
| Q3 FY2022 | Sep 30, 2022 | -111.2% | −55.8 |
| Q2 FY2022 | Jun 30, 2022 | -98.4% | −57.4 |
| Q1 FY2022 | Mar 31, 2022 | -89.6% | −62.7 |
| Q4 FY2021 | Dec 31, 2021 | -88.7% | −66.6 |
| Q3 FY2021 | Sep 30, 2021 | -55.4% | −36.8 |
| Q2 FY2021 | Jun 30, 2021 | -41.0% | −7.3 |
| Q1 FY2021 | Mar 31, 2021 | -26.9% | +1.6 |
| Q4 FY2020 | Dec 31, 2020 | -22.0% | +51.1 |
| Q3 FY2020 | Sep 30, 2020 | -18.6% | +73.7 |
| Q2 FY2020 | Jun 30, 2020 | -33.7% | +24.6 |
| Q1 FY2020 | Mar 31, 2020 | -28.5% | +54.1 |
| Q4 FY2019 | Dec 31, 2019 | -73.1% | +18.8 |
| Q3 FY2019 | Sep 30, 2019 | -92.3% | −45.1 |
| Q2 FY2019 | Jun 30, 2019 | -58.2% | +14.5 |
| Q1 FY2019 | Mar 31, 2019 | -82.5% | −19.6 |
| Q4 FY2018 | Dec 31, 2018 | -91.9% | −10.0 |
| Q3 FY2018 | Sep 30, 2018 | -47.2% | +9.0 |
| Q2 FY2018 | Jun 30, 2018 | -72.8% | −7.4 |
| Q1 FY2018 | Mar 31, 2018 | -63.0% | −12.9 |
| Q4 FY2017 | Dec 31, 2017 | -81.9% | +66.3 |
| Q3 FY2017 | Sep 30, 2017 | -56.2% | +32.7 |
| Q2 FY2017 | Jun 30, 2017 | -65.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -50.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -148.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -88.9% | – |
See a number that looks wrong?